1.0 Credit - CME/CPE | Expires 4/18/2015
This activity is supported by an educational grant from Allergan, Inc.
An Online E-Newsletter
William J. Cardarelli, PharmD
Director of Pharmacy Revenue and SupplyAtrius HealthHarvard Vanguard Medical AssociatesWatertown, Massachusetts
Contributing Editorial Support
Elizabeth Paczolt, MD, FACNM
Medical ConsultantChurchville, Pennsylvania
Neurogenic bladder (NGB) is a complex, highly prevalent disorder that is associated with numerous complications and considerable costs to the US health care system and society. Unfortunately, despite its detrimental impact on patient quality of life and its undeniable burden, the disease continues to be under-recognized, underdiagnosed, and undermanaged. In an effort to guide best clinical practices and optimal treatment strategies for NGB, Part 3 of this newsletter series carefully examines the patient-related implications, clinical burden, and health care utilization tied to NGB.
Medical directors, pharmacy directors, specialty pharmacists, and other managed care professionals who oversee the treatment of patients with neurogenic bladder.
Upon completion of this educational activity, the participant should be able to:
Release date: April 18, 2014
Expiration date: April 18, 2015
Estimated time to complete activity: 1.0 hours
Type of activity: Knowledge
Medium: Internet-based activity with polling questions, evaluation, and request for credit
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education. The University of Cincinnati is accredited by the
ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation and Credit Designation
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEUs) under the ACPE universal activity number 0290-9999-14-034-H01-P. The activity is available for CE credit through April 18, 2015.
Obtaining Credit: Participants must read the entire online e-Newsletter, take the pretest and posttest (achieving a passing score of 70% or higher), and complete the online evaluation. Once the activity evaluation has been submitted, participants can request their statement of credit.
For Physician credit (CME) only
For Pharmacy credit (CPE) only